Neostigmine Methylsulfate
- Product NDC
- 0641-6240
- 11-digit product format
- 006416240
- Labeler code
- 0641
- Product ID
- 0641-6240_521e4ee9-7150-4513-b9d5-7fc5cc9efd0a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine Methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA216206
- Marketing category
- ANDA
- Marketing start
- 2022-07-13
- Marketing end
- 0000-00-00
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0641-6240 | NEOSTIGMINE METHYLSULFATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] | 2 | Legacy NDC | 20240410_9afefbea-ea4a-48c5-ba51-42ece652eb7d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0641-6240-10 | 00641624010 | 10 SYRINGE, PLASTIC in 1 CARTON (0641-6240-10) > 3 mL in 1 SYRINGE, PLASTIC | 2022-07-13 | 0000-00-00 | No | No | Current |